Furthermore, a PTEN inhibitor BPV could appreciably prevent myocardial infarction in mice via promoting cardiomyocyte angiogenesis and activating the PI3K/AKT/VEGF signaling pathway [26]. The gene discussed is VEGFA; the disease is myocardial infarction.